Orbimed Advisors LLC Neuro Pace Inc Transaction History
Orbimed Advisors LLC
- $4.44 Billion
- Q1 2024
A detailed history of Orbimed Advisors LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Orbimed Advisors LLC holds 4,003,967 shares of NPCE stock, worth $27.7 Million. This represents 1.19% of its overall portfolio holdings.
Number of Shares
4,003,967
Previous 4,003,967
-0.0%
Holding current value
$27.7 Million
Previous $41.3 Million
28.03%
% of portfolio
1.19%
Previous 1.01%
Shares
2 transactions
Others Institutions Holding NPCE
# of Institutions
61Shares Held
18.7MCall Options Held
28.9KPut Options Held
7.5K-
Kck Ltd. Tortola, D85.62MShares$38.8 Million77.74% of portfolio
-
Morgan Stanley New York, NY2.48MShares$17.2 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$16.8 Million2.63% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT778KShares$5.38 Million0.66% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA644KShares$4.45 Million4.05% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $172M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...